Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco J D Tangelder

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Thrombosis and Haemostasis|May 29, 2010
Antithrombotic therapy in peripheral artery disease--antiplatelet therapy, anticoagulants, both or noneMarco J D Tangelder, Eline S van Hattum
Journal of Vascular Surgery|May 18, 2011
Regarding "a meta-analysis of clinical studies of statins for prevention of abdominal aortic aneurysm expansion"Rob Hurks, Marco J D Tangelder, Gerard Pasterkamp, et al.
Journal of Vascular Surgery|September 13, 2003
Veterans Affairs (VA) Cooperative Study #362Marco J D Tangelder, Alge Algra, James Lawson, et al.
Annals of the Rheumatic Diseases|August 5, 2006
The rate of NSAID-induced endoscopic ulcers increases linearly but not exponentially with age: a pooled analysis of 12 randomised trialsMaarten Boers, Marco J D Tangelder, Hein van Ingen, et al.
Thrombosis and Haemostasis|August 9, 2012
Long-term risk of vascular events after peripheral bypass surgery. A cohort studyEline S Van Hattum, Marco J D Tangelder, James A Lawson, et al.
Journal of Vascular Surgery|December 15, 2010
The quality of life in patients after peripheral bypass surgery deteriorates at long-term follow-upEline S van Hattum, Marco J D Tangelder, James A Lawson, et al.
American Heart Journal|January 25, 2008
Effect of ximelagatran on ischemic events and death in patients with atrial fibrillation after acute myocardial infarction in the efficacy and safety of the oral direct thrombin inhibitor ximelagatran in patients with recent myocardial damage (ESTEEM) trialMarco J D Tangelder, Lars Frison, Douglas Weaver, et al.
Circulation|October 7, 2009
Bleeding increases the risk of ischemic events in patients with peripheral arterial diseaseEline S van Hattum, Ale Algra, James A Lawson, et al.
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|March 27, 2015
A review of antithrombotic therapy and the rationale and design of the randomized edoxaban in patients with peripheral artery disease (ePAD) trial adding edoxaban or clopidogrel to aspirin after femoropopliteal endovascular interventionMarco J D Tangelder, Chuke E Nwachuku, Michael Jaff, et al.
Journal of Vascular Surgery|April 29, 2008
Growth predictors and prognosis of small abdominal aortic aneurysmsFelix J V Schlösser, Marco J D Tangelder, Hence J M Verhagen, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Thrombosis and Haemostasis|May 29, 2010
Antithrombotic therapy in peripheral artery disease--antiplatelet therapy, anticoagulants, both or noneMarco J D Tangelder, Eline S van Hattum
Journal of Vascular Surgery|May 18, 2011
Regarding "a meta-analysis of clinical studies of statins for prevention of abdominal aortic aneurysm expansion"Rob Hurks, Marco J D Tangelder, Gerard Pasterkamp, et al.
Journal of Vascular Surgery|September 13, 2003
Veterans Affairs (VA) Cooperative Study #362Marco J D Tangelder, Alge Algra, James Lawson, et al.
Annals of the Rheumatic Diseases|August 5, 2006
The rate of NSAID-induced endoscopic ulcers increases linearly but not exponentially with age: a pooled analysis of 12 randomised trialsMaarten Boers, Marco J D Tangelder, Hein van Ingen, et al.
Thrombosis and Haemostasis|August 9, 2012
Long-term risk of vascular events after peripheral bypass surgery. A cohort studyEline S Van Hattum, Marco J D Tangelder, James A Lawson, et al.
Journal of Vascular Surgery|December 15, 2010
The quality of life in patients after peripheral bypass surgery deteriorates at long-term follow-upEline S van Hattum, Marco J D Tangelder, James A Lawson, et al.
American Heart Journal|January 25, 2008
Effect of ximelagatran on ischemic events and death in patients with atrial fibrillation after acute myocardial infarction in the efficacy and safety of the oral direct thrombin inhibitor ximelagatran in patients with recent myocardial damage (ESTEEM) trialMarco J D Tangelder, Lars Frison, Douglas Weaver, et al.
Circulation|October 7, 2009
Bleeding increases the risk of ischemic events in patients with peripheral arterial diseaseEline S van Hattum, Ale Algra, James A Lawson, et al.
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|March 27, 2015
A review of antithrombotic therapy and the rationale and design of the randomized edoxaban in patients with peripheral artery disease (ePAD) trial adding edoxaban or clopidogrel to aspirin after femoropopliteal endovascular interventionMarco J D Tangelder, Chuke E Nwachuku, Michael Jaff, et al.
Journal of Vascular Surgery|April 29, 2008
Growth predictors and prognosis of small abdominal aortic aneurysmsFelix J V Schlösser, Marco J D Tangelder, Hence J M Verhagen, et al.
Pageof 1